These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17457119)

  • 21. [Care for the cardiopathy patient after percutaneous coronary intervention].
    Barrera-Ramírez CF; Pineda Pompa LR; Guzmán CE
    Gac Med Mex; 2004; 140(6):619-27. PubMed ID: 15633569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing subacute thrombosis.
    Pate G; Webb JG
    J Invasive Cardiol; 2002 Jul; 14(7):369-70. PubMed ID: 12082188
    [No Abstract]   [Full Text] [Related]  

  • 23. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives.
    Jaffe R; Strauss BH
    J Am Coll Cardiol; 2007 Jul; 50(2):119-27. PubMed ID: 17616295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One stent lost in two arteries.
    Goldberg A; Kemer A; Anne G; Gruberg L
    J Invasive Cardiol; 2004 Mar; 16(3):163-4. PubMed ID: 15152170
    [No Abstract]   [Full Text] [Related]  

  • 25. Hidden drugs, hidden risks--is cocaine use a new risk factor for stent thrombosis?
    Lemos PA
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):959-60. PubMed ID: 17525956
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-eluting coronary stents--promise and uncertainty.
    Curfman GD; Morrissey S; Jarcho JA; Drazen JM
    N Engl J Med; 2007 Mar; 356(10):1059-60. PubMed ID: 17296828
    [No Abstract]   [Full Text] [Related]  

  • 27. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late stent thrombosis--the "vulnerable" stent.
    Waksman R
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):54-6. PubMed ID: 17585385
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-eluting stent safety.
    Slottow TL; Waksman R
    Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
    Ryding AD; Banning AP
    Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815
    [No Abstract]   [Full Text] [Related]  

  • 33. Bioabsorbable drug-eluting stents: the future of coronary angioplasty?
    Macaya C; Moreno R
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):598-9. PubMed ID: 18679382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kounis syndrome: a potential cause of simultaneous multivessel coronary spasm and thrombosis after drug-eluting stent implantation.
    Kounis NG; Kounis GN; Soufras GD
    J Invasive Cardiol; 2007 Apr; 19(4):200-1; author reply 201. PubMed ID: 17404409
    [No Abstract]   [Full Text] [Related]  

  • 35. Subacute coronary stent thrombosis in cancer patients.
    Gross CM; Posch MG; Geier C; Olthoff H; Krämer J; Dechend R; Dietz R; Ozcelik C
    J Am Coll Cardiol; 2008 Mar; 51(12):1232-3. PubMed ID: 18355663
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study.
    Burzotta F; Parma A; Pristipino C; Manzoli A; Belloni F; Sardella G; Rigattieri S; Danesi A; Mazzarotto P; Summaria F; Romagnoli E; Prati F; Trani C; Crea F
    Eur Heart J; 2008 Dec; 29(24):3011-21. PubMed ID: 18987096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-eluting stents is their future as bright as their past?
    Kastrati A; Schömig A
    J Am Coll Cardiol; 2007 Jul; 50(2):146-8. PubMed ID: 17616298
    [No Abstract]   [Full Text] [Related]  

  • 38. Covered stents: a review.
    Jamshidi P; Mahmoody K; Erne P
    Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Percutaneous coronary intervention in patients with multiple diseases is not evidence-based. Risk of increasing long-term mortality because of indication sliding].
    Bjessmo S; Van der Linden J; Kjellman U
    Lakartidningen; 2007 Jun 4-11; 104(23):1780-2. PubMed ID: 17655021
    [No Abstract]   [Full Text] [Related]  

  • 40. [Benefits and risks of drug-eluting stents].
    Zijlstra F
    Ned Tijdschr Geneeskd; 2007 May; 151(18):1005-7. PubMed ID: 17508683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.